Risk factors for vitamin D deficiency in sickle cell disease

Jin Han, Xu Zhang, Santosh L. Saraf, Michel Gowhari, Robert E. Molokie, Johara Hassan, Shivi Jain, Binal N. Shah, Taimur Abbasi, Roberto Machado, Victor R. Gordeuk

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Vitamin D deficiency (VDD), 25-OHD levels <20 ng/ml, is prevalent among patients with sickle cell disease (SCD) and is linked to acute and chronic pain and bone fracture in this population. There is limited literature regarding VDD-associated risk factors for SCD. We examined potential clinical and genomic parameters associated with VDD in 335 adults with SCD in a cross-sectional study. VDD was present in 65% of adult SCD patients, and 25-OHD levels independently and positively correlated with older age (P < 0·001) and vitamin D supplementation (P < 0·001). 25-OHD levels were higher in SCD patients over 40 years of age compared to the general African-American population. Both lower 25-OHD levels and increased pain frequency were associated with increased expression of SLC6A5 encoding glycine transporter-2 (GlyT2), a protein involved in neuronal pain pathways. Lower 25-OHD levels were also associated with increased expression of CYP3A4, and with decreased expression of GC (also termed DBP) and VDR, three genes involved in vitamin D metabolism. We conclude that vitamin D supplementation should be an almost universal feature of the care of young adults with SCD, and that further research is warranted into genomic factors that regulate vitamin D metabolism in SCD.

Original languageEnglish (US)
JournalBritish Journal of Haematology
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Vitamin D Deficiency
Sickle Cell Anemia
Vitamin D
Glycine Plasma Membrane Transport Proteins
Cytochrome P-450 CYP3A
Pain
Bone Fractures
Acute Pain
Complement Factor D Deficiency
Chronic Pain
African Americans
Population
Young Adult
Cross-Sectional Studies
Research
Genes

Keywords

  • Gene expression
  • Mortality
  • Sickle
  • SLC6A5
  • Vitamin D

ASJC Scopus subject areas

  • Hematology

Cite this

Han, J., Zhang, X., Saraf, S. L., Gowhari, M., Molokie, R. E., Hassan, J., ... Gordeuk, V. R. (Accepted/In press). Risk factors for vitamin D deficiency in sickle cell disease. British Journal of Haematology. https://doi.org/10.1111/bjh.15270

Risk factors for vitamin D deficiency in sickle cell disease. / Han, Jin; Zhang, Xu; Saraf, Santosh L.; Gowhari, Michel; Molokie, Robert E.; Hassan, Johara; Jain, Shivi; Shah, Binal N.; Abbasi, Taimur; Machado, Roberto; Gordeuk, Victor R.

In: British Journal of Haematology, 01.01.2018.

Research output: Contribution to journalArticle

Han, J, Zhang, X, Saraf, SL, Gowhari, M, Molokie, RE, Hassan, J, Jain, S, Shah, BN, Abbasi, T, Machado, R & Gordeuk, VR 2018, 'Risk factors for vitamin D deficiency in sickle cell disease', British Journal of Haematology. https://doi.org/10.1111/bjh.15270
Han, Jin ; Zhang, Xu ; Saraf, Santosh L. ; Gowhari, Michel ; Molokie, Robert E. ; Hassan, Johara ; Jain, Shivi ; Shah, Binal N. ; Abbasi, Taimur ; Machado, Roberto ; Gordeuk, Victor R. / Risk factors for vitamin D deficiency in sickle cell disease. In: British Journal of Haematology. 2018.
@article{1629a182b72f49fb85b5c9e6a424a504,
title = "Risk factors for vitamin D deficiency in sickle cell disease",
abstract = "Vitamin D deficiency (VDD), 25-OHD levels <20 ng/ml, is prevalent among patients with sickle cell disease (SCD) and is linked to acute and chronic pain and bone fracture in this population. There is limited literature regarding VDD-associated risk factors for SCD. We examined potential clinical and genomic parameters associated with VDD in 335 adults with SCD in a cross-sectional study. VDD was present in 65{\%} of adult SCD patients, and 25-OHD levels independently and positively correlated with older age (P < 0·001) and vitamin D supplementation (P < 0·001). 25-OHD levels were higher in SCD patients over 40 years of age compared to the general African-American population. Both lower 25-OHD levels and increased pain frequency were associated with increased expression of SLC6A5 encoding glycine transporter-2 (GlyT2), a protein involved in neuronal pain pathways. Lower 25-OHD levels were also associated with increased expression of CYP3A4, and with decreased expression of GC (also termed DBP) and VDR, three genes involved in vitamin D metabolism. We conclude that vitamin D supplementation should be an almost universal feature of the care of young adults with SCD, and that further research is warranted into genomic factors that regulate vitamin D metabolism in SCD.",
keywords = "Gene expression, Mortality, Sickle, SLC6A5, Vitamin D",
author = "Jin Han and Xu Zhang and Saraf, {Santosh L.} and Michel Gowhari and Molokie, {Robert E.} and Johara Hassan and Shivi Jain and Shah, {Binal N.} and Taimur Abbasi and Roberto Machado and Gordeuk, {Victor R.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/bjh.15270",
language = "English (US)",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Risk factors for vitamin D deficiency in sickle cell disease

AU - Han, Jin

AU - Zhang, Xu

AU - Saraf, Santosh L.

AU - Gowhari, Michel

AU - Molokie, Robert E.

AU - Hassan, Johara

AU - Jain, Shivi

AU - Shah, Binal N.

AU - Abbasi, Taimur

AU - Machado, Roberto

AU - Gordeuk, Victor R.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Vitamin D deficiency (VDD), 25-OHD levels <20 ng/ml, is prevalent among patients with sickle cell disease (SCD) and is linked to acute and chronic pain and bone fracture in this population. There is limited literature regarding VDD-associated risk factors for SCD. We examined potential clinical and genomic parameters associated with VDD in 335 adults with SCD in a cross-sectional study. VDD was present in 65% of adult SCD patients, and 25-OHD levels independently and positively correlated with older age (P < 0·001) and vitamin D supplementation (P < 0·001). 25-OHD levels were higher in SCD patients over 40 years of age compared to the general African-American population. Both lower 25-OHD levels and increased pain frequency were associated with increased expression of SLC6A5 encoding glycine transporter-2 (GlyT2), a protein involved in neuronal pain pathways. Lower 25-OHD levels were also associated with increased expression of CYP3A4, and with decreased expression of GC (also termed DBP) and VDR, three genes involved in vitamin D metabolism. We conclude that vitamin D supplementation should be an almost universal feature of the care of young adults with SCD, and that further research is warranted into genomic factors that regulate vitamin D metabolism in SCD.

AB - Vitamin D deficiency (VDD), 25-OHD levels <20 ng/ml, is prevalent among patients with sickle cell disease (SCD) and is linked to acute and chronic pain and bone fracture in this population. There is limited literature regarding VDD-associated risk factors for SCD. We examined potential clinical and genomic parameters associated with VDD in 335 adults with SCD in a cross-sectional study. VDD was present in 65% of adult SCD patients, and 25-OHD levels independently and positively correlated with older age (P < 0·001) and vitamin D supplementation (P < 0·001). 25-OHD levels were higher in SCD patients over 40 years of age compared to the general African-American population. Both lower 25-OHD levels and increased pain frequency were associated with increased expression of SLC6A5 encoding glycine transporter-2 (GlyT2), a protein involved in neuronal pain pathways. Lower 25-OHD levels were also associated with increased expression of CYP3A4, and with decreased expression of GC (also termed DBP) and VDR, three genes involved in vitamin D metabolism. We conclude that vitamin D supplementation should be an almost universal feature of the care of young adults with SCD, and that further research is warranted into genomic factors that regulate vitamin D metabolism in SCD.

KW - Gene expression

KW - Mortality

KW - Sickle

KW - SLC6A5

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=85047561171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047561171&partnerID=8YFLogxK

U2 - 10.1111/bjh.15270

DO - 10.1111/bjh.15270

M3 - Article

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

ER -